Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/17974| Title: | BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned. | Austin Authors: | Hayne, Dickon;Stockler, Martin;McCombie, Steve P;Lawrence, Nicola;Martin, Andrew;Sengupta, Shomik ;Davis, Ian D | Affiliation: | Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Camperdown, NSW, Australia University of Western Australia Medical School, Crawley, WA, Australia Fiona Stanley Hospital Urology, Murdoch, WA, Australia NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia Department of Urology, Austin Health, Heidelberg, Victoria, Australia Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia Ludwig Institute for Cancer Research, Austin Health, Heidelberg, Victoria, Australia Monash University Eastern Health Clinical School, Box Hill, Victoria, Australia |
Issue Date: | May-2017 | Publication information: | BJU International 2017; 119 (Suppl 5): 55-57 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/17974 | DOI: | 10.1111/bju.13873 | ORCID: | 0000-0002-3920-994X 0000-0003-3357-1216 |
Journal: | BJU International | PubMed URL: | 28391606 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.